Cases & Deals

  • Home
  • Practices
  • Publicly traded life sciences company conducts FCPA investigation of China whistleblower allegations and assessment of local government enforcement action

Share

Publicly traded life sciences company conducts FCPA investigation of China whistleblower allegations and assessment of local government enforcement action

December 2016

Client(s) Publicly traded life sciences company

Jones Day assisted a publicly traded life sciences company with its investigation of allegations that senior management in China helped distributors evade the company's anti-corruption controls in potential violation of the FCPA. Jones Day further advised the company regarding potential FCPA liability arising from Chinese government enforcement actions alleging violations of local anti-corruption laws.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.